Inhibition of topoisomerase I shapes antitumor immunity through the induction of monocyte-derived dendritic cells

CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models

Yu Zhu, Brett L. Knolhoff, Melissa A. Meyer et al. · Cancer Research · 2014 · 1.3K citations · Full text

Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity

Eiji Suzuki, Veena Kapoor, Arminder S. Jassar et al. · Clinical Cancer Research · 2005 · 1K citations

Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

Joachim von Pawel, Joan H. Schiller, Frances A. Shepherd et al. · Journal of Clinical Oncology · 1999 · 943 citations

A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers

Krithika N. Kodumudi, Karrune Woan, Danielle L. Gilvary et al. · Clinical Cancer Research · 2010 · 495 citations · Full text

Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner

Carlos W. Wanderley, David F. Cólon, João Paulo Mesquita Luiz et al. · Cancer Research · 2018 · 405 citations · Full text